Back to mobile site

BofA Securities Reiterates Buy Rating on BioNTech (BNTX)

November 4, 2024 12:47 PM EST Send to a Friend
BofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $150.00 price target on BioNTech (NASDAQ: BNTX).The analyst comments "BioNTech ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login